Though some publications reported no relationship between HbA1c or blood glucose level and CSF Aβ1-42, pTau level [174,175], diabetic condition promoted higher level of CSF p-tau in AD patients carrying the APOE4 genotype [176]. The gene discussed is MAPT; the disease is Alzheimer disease.